Analysis Cytek Biosciences: Investors Await Full-Year Financials and 2026 Outlook
As Cytek Biosciences navigates its regulatory quiet period, the investment community is looking ahead to the imminent release of its complete fourth-quarter and full-year 2025 financial results. Preliminary revenue figures...